US Healthcare Journal
SEE OTHER BRANDS

Get your fresh news on healthcare and wellness in the United States

US Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.

Press releases published on March 13, 2025

U.S. Contract Research Organization (CROs) Market Set to Witness Significant Growth by 2025-2032: IQVIA INC., ICON plc

U.S. Contract Research Organization (CROs) Market Set to Witness Significant Growth by 2025-2032: IQVIA INC., ICON plc

U.S. Contract Research Organization (CROs) Market is expected to reach USD 49.56 Bn by 2032, exhibiting a compound annual growth rate of 12.4% from 2025 to 2032 BURLINGAME, CA, UNITED STATES, March 12, 2025 /⁨EINPresswire.com⁩/ -- Latest Report, titled “U …

Plasma Fractionation Market Projected To Witness Substantial Growth, 2025-2032: Octapharma AG, Grifols S.A, Biotest AG

Plasma Fractionation Market Projected To Witness Substantial Growth, 2025-2032: Octapharma AG, Grifols S.A, Biotest AG

Plasma Fractionation is a process of separating various components of plasma, which in turn is a component of blood obtained through blood fractionation. BURLINGAME, CA, UNITED STATES, March 12, 2025 /⁨EINPresswire.com⁩/ -- Latest Report, titled “Plasma …

U.S. Ambulatory Surgery Center Market Set to Witness Significant Growth by 2025-2032: AmSurg Corp., Surgery Partners

U.S. Ambulatory Surgery Center Market Set to Witness Significant Growth by 2025-2032: AmSurg Corp., Surgery Partners

U.S. ambulatory surgery center market is estimated to be valued at US$ 65.58 Bn in 2023, exhibiting CAGR of 5.2% during the forecast period (2023-2030). BURLINGAME, CA, UNITED STATES, March 12, 2025 /⁨EINPresswire.com⁩/ -- Latest Report, titled “U.S. …

nuEra Cannabis Expands Medical Cannabis Access for Women’s Health

nuEra Cannabis Expands Medical Cannabis Access for Women’s Health

CHICAGO, March 13, 2025 (GLOBE NEWSWIRE) -- This Women’s Month, nuEra Cannabis is championing expanded access to medical cannabis for women by raising awareness about newly added qualifying conditions in Illinois’ medical cannabis program. The Illinois …

PALTmed & LTC ACO Launch Value-Based Care Joint Alliance

PALTmed & LTC ACO Launch Value-Based Care Joint Alliance

KENNETT SQUARE, Pa., March 13, 2025 (GLOBE NEWSWIRE) -- Post-Acute and Long-Term Care Medical Association (PALTmed), the leading medical specialty society dedicated to supporting clinicians in post-acute and long-term care (PALTC) settings, and LTC ACO, …

Academy of Nutrition and Dietetics Celebrates Nutrition and Dietetics Technician, Registered Day, March 13, During National Nutrition Month®

Academy of Nutrition and Dietetics Celebrates Nutrition and Dietetics Technician, Registered Day, March 13, During National Nutrition Month®

Chicago, March 13, 2025 (GLOBE NEWSWIRE) -- Today, March 13, the Academy of Nutrition and Dietetics is proud to shine a spotlight on the important work of nutrition and dietetics technician, registered (NDTRs) in celebration of Nutrition and Dietetics …

Shaenfield Pediatric Dentistry Welcomes New Dentist Dr. Natalia Velasquez to Their Team

Shaenfield Pediatric Dentistry Welcomes New Dentist Dr. Natalia Velasquez to Their Team

Shaenfield Pediatric Dentistry is excited to announce the addition of Dr. Natalia Velasquez to their dental team, enhancing their pediatric dental services. SAN ANTONIO, TX, UNITED STATES, March 12, 2025 /⁨EINPresswire.com⁩/ -- Shaenfield Pediatric …

Aclarion Provides Shareholder Update

Aclarion Provides Shareholder Update

BROOMFIELD, Colo., March 13, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help …

FDA Issues Clearance for ReWalk 7 Exoskeleton

FDA Issues Clearance for ReWalk 7 Exoskeleton

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or …

Zeranovia(TM) Weight Loss Product Shows Promising Results in Dosage Trial

Zeranovia(TM) Weight Loss Product Shows Promising Results in Dosage Trial

LAS VEGAS, March 13, 2025 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives Inc. (OTC: BDPT) today announced the successful completion of dosage trials for its innovative weight loss product, Zeranovia™. The trial demonstrated significant weight loss results …

Tots to Teens Marks 13 Years of Dental Care in Underserved Areas

Tots to Teens Marks 13 Years of Dental Care in Underserved Areas

From One to Five Locations: A Journey of Commitment and Comprehensive Pediatric Dental Services SAN ANTONIO, TX, UNITED STATES, March 12, 2025 /⁨EINPresswire.com⁩/ -- Tots to Teens Pediatric Dentistry …

NEXGEL to Participate in the iAccess Alpha Virtual Best Ideas Spring Investment Conference on March 25-26th, 2025

NEXGEL to Participate in the iAccess Alpha Virtual Best Ideas Spring Investment Conference on March 25-26th, 2025

LANGHORNE, Pa., March 13, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer …

Solésence Wins Best Prestige Finished Formula at the 2025 Cosmetics & Toiletries Allē Awards, Marking Third Consecutive Win

Solésence Wins Best Prestige Finished Formula at the 2025 Cosmetics & Toiletries Allē Awards, Marking Third Consecutive Win

ROMEOVILLE, Ill., March 13, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that their market-ready product, Au Lait Face Milk SPF 50 …

Dogwood Therapeutics, Inc. Announces Pricing of $4.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Dogwood Therapeutics, Inc. Announces Pricing of $4.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Proceeds from today’s financing, when added to existing cash, fund operations through Q1 2026 The Company is planning to announce interim data from its ongoing Halneuron® Phase 2b chemotherapy induced neuropathic pain (“CINP”) trial in Q4 2025 ATLANTA, …

Bionano Announces Publication Reporting First Use of OGM to Detect Chromoanagenesis, a Key Marker of Poor Prognosis in AML

Bionano Announces Publication Reporting First Use of OGM to Detect Chromoanagenesis, a Key Marker of Poor Prognosis in AML

In-Motion Webinar: Bionano will host a webinar featuring the study’s lead author, Dr. Guilin Tang, who will discuss the study and its findings in detail, including a summary of the potential implications for wide-spread adoption of optical genome mapping …

The International Myeloma Foundation Announces 2nd Annual Iceland Cycling Expedition, to be Held from August 27 – September 2

The International Myeloma Foundation Announces 2nd Annual Iceland Cycling Expedition, to be Held from August 27 – September 2

STUDIO CITY, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) is excited to announce that the 2nd annual Iceland Cycling Expedition (ICE)—a 6-night/7-day endurance fundraiser biking expedition —will take place from …

SS Innovations Unveils India’s First Mobile Tele-Surgical Unit at SMRSC 2025

SS Innovations Unveils India’s First Mobile Tele-Surgical Unit at SMRSC 2025

  FORT LAUDERDALE, Fla., March 13, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery …

Femasys Announces FemBloc Delivery System Approval in Europe; A Significant Step Towards FemBloc Permanent Birth Control Availability as the First-Ever Non-Surgical Approach

Femasys Announces FemBloc Delivery System Approval in Europe; A Significant Step Towards FemBloc Permanent Birth Control Availability as the First-Ever Non-Surgical Approach

ATLANTA, March 13, 2025 (GLOBE NEWSWIRE) -- Femasys Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive, accessible, in-office therapeutic and diagnostic …

Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs

Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs

NYC Building …

Novartis Pharmaceuticals and Folia Health Partner on Innovative App-Based Study to Assess Real-World Experience of IgA Nephropathy

Novartis Pharmaceuticals and Folia Health Partner on Innovative App-Based Study to Assess Real-World Experience of IgA Nephropathy

BOSTON, March 13, 2025 (GLOBE NEWSWIRE) -- Today, Folia Health and Novartis Pharmaceuticals, Inc. proudly announce their collaboration on an innovative, at-home observational real-world evidence initiative supporting individuals with IgA nephropathy. This …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service